← back to search

Adi F. Gazdar

Weatherford College · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, RNA modifications and cancer, Lung Cancer Research Studies, and Epigenetics and DNA Methylation.
h-index
161
citations
115,121
works
1,240
NIH funding
primary concept
email

Recent publications

ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers
2023cited by 1position: contributordoi
Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
Communications Biology 2021cited by 101position: lastdoi
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Journal of Clinical Investigation 2020cited by 74position: middledoi
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Nature reviews. Cancer 2019cited by 1,265position: lastdoi
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Nature reviews. Cancer 2019cited by 36position: lastdoi
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes
Translational Lung Cancer Research 2018cited by 280position: lastdoi
Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
Cell Metabolism 2018cited by 199position: middledoi
Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome
Scientific Reports 2018cited by 148position: middledoi
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Cancer Cell 2017cited by 605position: middledoi
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Cancer Cell 2017cited by 235position: middledoi
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
Nature Communications 2017cited by 115position: middledoi
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Journal of Thoracic Oncology 2016cited by 182position: middledoi
Abstract 4367: Accelerating prediction of tumor vulnerabilities using next-generation cancer models
Cancer Research 2016cited by 0position: middledoi
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
Journal of Thoracic Oncology 2015cited by 323position: middledoi
Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
Cancer Research 2015cited by 220position: middledoi
The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung
Journal of Thoracic Oncology 2015cited by 128position: firstdoi
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Proceedings of the National Academy of Sciences 2014cited by 283position: middledoi
Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
Human Mutation 2014cited by 233position: middledoi
Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
PLoS ONE 2013cited by 60position: middledoi
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Nature Genetics 2012cited by 1,095position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John D. Minna · Weatherford College9 papers (2014–2023)Luc Girard · Southwestern Medical Center4 papers (2014–2018)Jane E. Johnson · Southwestern Medical Center4 papers (2014–2019)Trudy G. Oliver · Duke University4 papers (2018–2019)Lauren A. Byers · The University of Texas MD Anderson Cancer Center3 papers (2017–2019)Julien Sage · Stanford Medicine3 papers (2015–2019)David MacPherson · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa3 papers (2015–2019)John V. Heymach · 1The University of Texas MD Anderson Cancer Center3 papers (2017–2019)Pierre P. Massion · Vanderbilt University2 papers (2019–2019) · 2 papers (2019–2019)Yu‐An Zhang · Sanofi (United States)2 papers (2015–2018)Hans K. Ghayee · The University of Texas Southwestern Medical Center2 papers (2013–2018)Junya Fujimoto · The University of Texas MD Anderson Cancer Center2 papers (2014–2018)Yang Xie · Southwestern Medical Center2 papers (2014–2018)Julie George · University of Cologne2 papers (2019–2019)Vito Quaranta · Vanderbilt University2 papers (2019–2019)Carmen Behrens · University of Illinois Chicago2 papers (2014–2015)John T. Poirier · NYU Langone Health2 papers (2019–2019)Christopher R. Vakoc · University Children's Hospital Zurich2 papers (2019–2019)Ling Cai · Duke University2 papers (2018–2018)